KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) EPS (Basic) (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of EPS (Basic) readings, the most recent being -$1.42 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 27.55% to -$1.42 in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.65, a 46.6% increase, with the full-year FY2025 number at -$5.64, up 46.49% from a year prior.
  • EPS (Basic) hit -$1.42 in Q4 2025 for Ginkgo Bioworks Holdings, up from -$1.45 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.04 in Q2 2021 to a low of -$48.96 in Q4 2022.
  • Median EPS (Basic) over the past 5 years was -$1.14 (2021), compared with a mean of -$3.92.
  • Biggest five-year swings in EPS (Basic): surged 91.26% in 2023 and later plummeted 4600.0% in 2024.
  • Ginkgo Bioworks Holdings' EPS (Basic) stood at -$1.17 in 2021, then crashed by 4084.62% to -$48.96 in 2022, then surged by 91.26% to -$4.28 in 2023, then skyrocketed by 54.21% to -$1.96 in 2024, then grew by 27.55% to -$1.42 in 2025.
  • The last three reported values for EPS (Basic) were -$1.42 (Q4 2025), -$1.45 (Q3 2025), and -$1.1 (Q2 2025) per Business Quant data.